Ameriprise Financial Inc Grifols Sa Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$5.47 - $11.38 $608,395 - $1.27 Million	-111,224 Reduced 91.38%	10,497 $70,000
Q4 2023 Feb 14, 2024	SELL	$7.71 - $11.56 $112,087 - $168,059	-14,538 Reduced 10.67%	121,721 $1.41 Million
Q3 2023 Nov 14, 2023	SELL	$8.91 - $10.91 $336,058 - $411,492	-37,717 Reduced 21.68%	136,259 $1.25 Million
Q2 2023 Aug 14, 2023	BUY	$7.14 - $9.29 $191,044 - $248,572	26,757 Added 18.17%	173,976 $1.59 Million
Q1 2023 May 15, 2023	SELL	$6.65 - $10.69 $884,310 - $1.42 Million	-132,979 Reduced 47.46%	147,219 $1.09 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $270,750 - $387,500	45,428 Added 19.35%	280,198 $2.38 Million
Q3 2022 Nov 14, 2022	BUY	$5.95 - $14.3 $42,441 - $102,001	7,133 Added 3.13%	234,770 $1.44 Million
Q2 2022 Aug 15, 2022	SELL	$10.6 - $13.28 $1.18 Million - $1.48 Million	-111,213 Reduced 32.82%	227,637 $2.7 Million
Q1 2022 May 16, 2022	BUY	$10.37 - $12.73 $661,377 - $811,893	63,778 Added 23.19%	338,850 $3.96 Million
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $813,144 - $1.22 Million	79,642 Added 40.75%	275,072 $3.09 Million
Q3 2021 Nov 15, 2021	SELL	$14.07 - $17.3 $303,912 - $373,680	-21,600 Reduced 9.95%	195,430 $2.85 Million
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $161,396 - $183,926	9,711 Added 4.68%	217,030 $3.77 Million
Q1 2021 May 17, 2021	BUY	$15.15 - $19.78 $252,671 - $329,890	16,678 Added 8.75%	207,319 $3.59 Million
Q4 2020 Feb 12, 2021	SELL	$16.86 - $19.67 $28.4 Million - $33.1 Million	-1,685,098 Reduced 89.84%	190,641 $3.52 Million
Q3 2020 Nov 16, 2020	SELL	$15.4 - $20.16 $18.1 Million - $23.7 Million	-1,177,196 Reduced 38.56%	1,875,739 $32.5 Million
Q2 2020 Aug 14, 2020	SELL	$18.24 - $21.45 $1.28 Million - $1.5 Million	-69,981 Reduced 2.24%	3,052,935 $55.7 Million
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $23.7 Million - $37.3 Million	-1,454,904 Reduced 31.78%	3,122,916 $62.1 Million
Q4 2019 Feb 14, 2020	SELL	$19.57 - $23.52 $24.8 Million - $29.8 Million	-1,265,961 Reduced 21.66%	4,577,820 $107 Million
Q3 2019 Nov 14, 2019	SELL	$19.85 - $22.76 $880,565 - $1.01 Million	-44,361 Reduced 0.75%	5,843,781 $117 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $3.18 Million - $3.82 Million	180,937 Added 3.17%	5,888,142 $124 Million
Q1 2019 May 15, 2019	BUY	$18.01 - $20.11 $2.35 Million - $2.62 Million	130,516 Added 2.34%	5,707,205 $115 Million
Q4 2018 Feb 14, 2019	SELL	$17.44 - $21.53 $9.48 Million - $11.7 Million	-543,629 Reduced 8.88%	5,576,689 $102 Million
Q3 2018 Nov 14, 2018	SELL	$19.97 - $21.96 $54,997 - $60,477	-2,754 Reduced 0.04%	6,120,318 $131 Million
Q2 2018 Aug 14, 2018	BUY	$20.16 - $24.68 $36.1 Million - $44.2 Million	1,791,021 Added 41.34%	6,123,072 $132 Million
Q1 2018 May 15, 2018	BUY	$20.31 - $24.95 $43.4 Million - $53.3 Million	2,134,892 Added 97.17%	4,332,051 $91.8 Million
Q4 2017 Feb 12, 2018	BUY	$20.99 - $23.89 $2.99 Million - $3.4 Million	142,397 Added 6.93%	2,197,159 $50.4 Million
Q3 2017 Nov 07, 2017	BUY	$20.07 - $21.89 $41.2 Million - $45 Million	2,054,762	2,054,762 $45 Million

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

Capital World Investors Los Angeles, CA

21M
Shares

$165 Million
0.03% of portfolio
Brandes Investment Partners, LP La Jolla, CA

19.9M
Shares

$156 Million
2.11% of portfolio
Permian Investment Partners, LP New York, NY

12.3M
Shares

$96.8 Million
16.06% of portfolio
Black Creek Investment Management Inc. Toronto, A6

11.1M
Shares

$87.2 Million
3.5% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

10.7M
Shares

$84.2 Million
0.05% of portfolio

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account